Background: Alzheimer's disease is a progressive disease that degrades cognitive functioning and ultimately results in death. Currently, there is no cure for Alzheimer's disease and, hence, the identification of preventative strategies is important. Physical activity (PA) is a behavioral intervention that holds promise with respect to delaying the onset of Alzheimer's disease. Purpose: The purpose of this study was to explore the differential cognitive benefits achieved in response to PA as a function of a person's genetic risk for AD. Methods: Older cognitively normal adults (50-65 years) with a family history of AD (FHxAD) participated in an 8-month PA program. Cognitive performance was measured at baseline, pretest, midtest, and posttest and changes over time were assessed as a function of apolipoprotein E (APOE) status (carriers: 1-2 copies of the ɛ4 allele; noncarriers: 0 copies of the ɛ4 allele). Results: Improvements in memory were associated with PA participation irrespective of APOE ɛ4 carrier status. Conclusions: Future experimental studies are needed to confirm that PA causes improvements to cognitive performance in older cognitively normal adults with a FHxAD and that these improvements are equivalent for cognitively normal APOE ɛ4 carriers and noncarriers.
Background: Alzheimer's disease is a progressive disease that degrades cognitive functioning and ultimately results in death. Currently, there is no cure for Alzheimer's disease and, hence, the identification of preventative strategies is important. Physical activity (PA) is a behavioral intervention that holds promise with respect to delaying the onset of Alzheimer's disease. Purpose: The purpose of this study was to explore the differential cognitive benefits achieved in response to PA as a function of a person's genetic risk for AD. Methods: Older cognitively normal adults (50-65 years) with a family history of AD (FHxAD) participated in an 8-month PA program. Cognitive performance was measured at baseline, pretest, midtest, and posttest and changes over time were assessed as a function of apolipoprotein E (APOE) status (carriers: 1-2 copies of the ɛ4 allele; noncarriers: 0 copies of the ɛ4 allele). Results: Improvements in memory were associated with PA participation irrespective of APOE ɛ4 carrier status. Conclusions: Future experimental studies are needed to confirm that PA causes improvements to cognitive performance in older cognitively normal adults with a FHxAD and that these improvements are equivalent for cognitively normal APOE ɛ4 carriers and noncarriers.
Authors: Sean P Deeny; David Poeppel; Jo B Zimmerman; Stephen M Roth; Josef Brandauer; Sarah Witkowski; Joseph W Hearn; Andrew T Ludlow; José L Contreras-Vidal; Jason Brandt; Bradley D Hatfield Journal: Biol Psychol Date: 2008-03-02 Impact factor: 3.251
Authors: Patrick J Smith; James A Blumenthal; Benson M Hoffman; Harris Cooper; Timothy A Strauman; Kathleen Welsh-Bohmer; Jeffrey N Browndyke; Andrew Sherwood Journal: Psychosom Med Date: 2010-03-11 Impact factor: 4.312
Authors: Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman Journal: N Engl J Med Date: 2009-07-16 Impact factor: 91.245
Authors: T Gomez-Isla; H L West; G W Rebeck; S D Harr; J H Growdon; J J Locascio; T T Perls; L A Lipsitz; B T Hyman Journal: Ann Neurol Date: 1996-01 Impact factor: 10.422
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Kyoung Shin Park; Alexis B Ganesh; Nathaniel T Berry; Yashonda P Mobley; William B Karper; Jeffrey D Labban; Christopher N Wahlheim; Tomika M Williams; Laurie Wideman; Jennifer L Etnier Journal: BMC Neurol Date: 2020-06-06 Impact factor: 2.474
Authors: Janina Krell-Roesch; Jeremy A Syrjanen; Maria Vassilaki; Bettina Barisch-Fritz; Sandra Trautwein; Klaus Boes; Alexander Woll; Walter K Kremers; Mary M Machulda; Michelle M Mielke; David S Knopman; Ronald C Petersen; Yonas E Geda Journal: Eur J Ageing Date: 2019-04-12
Authors: Janina Krell-Roesch; Jeremy A Syrjanen; Jelena Bezold; Sandra Trautwein; Bettina Barisch-Fritz; Klaus Boes; Alexander Woll; Erica Forzani; Walter K Kremers; Mary M Machulda; Michelle M Mielke; David S Knopman; Ronald C Petersen; Maria Vassilaki; Yonas E Geda Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160